Related Experiment Video
Updated: Feb 18, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
Idiopathic macular telangiectasia type 2: Prevalence and a morphometric and phenotypic study
R M Bayón-Porras1, I Pascual-Camps2, C Plaza-Laguardia3
1Servicio de Oftalmología, Hospital Nuestra Señora de la Montaña, Cáceres, España.
The prevalence of Type 2 idiopathic macular telangiectasia (MacTel2) is 0.12%. Multimodal imaging aids diagnosis and follow-up, with stable visual acuity and adequate response to anti-VEGF treatment for choroidal neovascularization.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Imaging
Background:
- Type 2 idiopathic macular telangiectasia (MacTel2) is a rare retinal condition requiring better definition.
- Understanding its clinical and functional characteristics is crucial for patient management.
Purpose of the Study:
- To define MacTel2's clinical features using multimodal imaging.
- To assess functional characteristics and disease prevalence.
- To evaluate treatment outcomes for associated complications.
Main Methods:
- Retrospective analysis of 12 eyes from 6 MacTel2 patients.
- Utilized multimodal imaging: fundus photography, autofluorescence, fluorescein angiography, OCT, and OCT-angiography.
- Prospectively recorded visual acuity over an 18-month follow-up.
Main Results:
- MacTel2 prevalence estimated at 0.12% in a specialized unit.
- Multimodal imaging provided detailed clinical feature insights.
- Visual acuity remained stable; three patients developed choroidal neovascularization (CNV) and responded to anti-VEGF therapy.
Conclusions:
- The study confirms a 0.12% prevalence for MacTel2.
- Multimodal imaging enhances diagnosis and monitoring of MacTel2.
- Anti-VEGF treatment appears effective for CNV in MacTel2 patients, warranting further investigation.
More Related Videos
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023